Vaishali Pharma

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue10.6113.9020.6226.7713.78
Expenses8.6011.2417.0726.1511.66
EBITDA2.633.334.091.312.67
EBIT2.553.193.971.162.55
Profit Before Tax2.012.653.550.632.12
Net Profit1.511.992.660.441.59
Financial Ratios
Operating Profit Margin25.83%25.25%20.31%16.67%19.90%
Net Profit Margin14.83%15.09%13.24%9.47%11.85%
Earning Per Share (Diluted)1.431.892.520.061.41
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ